Vimarsana.com

Latest Breaking News On - Cap research - Page 2 : vimarsana.com

Kineta to Present at the Life Sciences Investor Forum December 14th

Kineta to Present at the Life Sciences Investor Forum December 14th
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

John-vandermosten
Jacques-bouchy
Shawn-iadonato
Johnm-viglotti
John-mullaly
Cap-research
Linkedin
Facebook
Lifesci-advisors
Life-science-investor-forum
Kineta-inc
Corporate-services

Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

BETHESDA, Md., Dec. 04, 2023 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today.

John-vandermosten
Matthias-alder
Susan-sharpe
Linnden-communications
Gain-therapeutics-inc
Linkedin
Family-office
Nasdaq
Cap-research
Chief-executive-officer
Senior-analyst
Zacks-small-cap-research

Ayro, Inc. (NASDAQ:AYRO) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to Ayro Inc. Third Quarter 2023 Financial Results and Corporate Update Conference Call.

Florida
United-states
Joey-delahoussaye
Dave-hollingsworth
Tom-wittenschlaeger
Brian-lantier
Company-investor-relations
Company-club-car-current
Cap-research
Nasdaq
Ayro-inc
Call-transcript-november

Zacks Small Cap Research Report

Zacks Small Cap Research Report
insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.

Chicago
Illinois
United-states
Riverside-plaza
Bermuda
America
American
Tom-kerr
Selective-insurance-group-inc
Zacks-investment-research
Insurance-holdings-inc
Canopius-us-insurance-inc

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the BrainStorm Cell Therapeutics Third Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder, this call is being recorded.

Michael-wood
David-bautz
Stacy-lindborg
William-barr
Juno-pharma
Chaim-lebovits
Advisory-committee
Brainstorm-cell-therapeutics-inc
Cap-research
Nasdaq
Brainstorm-cell-therapeutics
Call-transcript-november

Sadot's Strategic Pivot Looks Like It's Paying Off As Analysts Forecast 360% Year-Over-Year Jump In Annual Revenue For 2023

Sadot's Strategic Pivot Looks Like It's Paying Off As Analysts Forecast 360% Year-Over-Year Jump In Annual Revenue For 2023
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Zambia
Michigan
United-states
Yorkville
Tommy-atkins
Sadot-group-inc
Cap-research
Rachael-green
Zacks-small-cap-research
Standby-equity-purchase-agreement
Yorkville-advisors

Sadot's Strategic Pivot Looks Like It's Paying Off As Analysts Forecast 360% Year-Over-Year Jump In Annual Revenue For 2023 - Sadot Group (NASDAQ:SDOT)

This month, Zacks Small-Cap Research published a report on Sadot Group Inc (NASDAQ: SDOT), maintaining that it believes the emerging agri-food supply chain solutions company is worth $4 per share.

Zambia
Tommy-atkins
Sadot-group-inc
Cap-research
Zacks-small-cap-research
Sadot-group
Standby-equity-purchase-agreement
Yorkville-advisors
Gozha-net

vimarsana © 2020. All Rights Reserved.